topotecan has been researched along with ammonium hydroxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, BD; Fugit, KD; Jyoti, A; Upreti, M | 1 |
| Kemmochi, S; Kimura, T; Makita-Suzuki, K; Matulonis, UA; Mori, M; Morohashi, Y; Nakayama, S; Okada, K; Shimoyama, S | 1 |
2 other study(ies) available for topotecan and ammonium hydroxide
| Article | Year |
|---|---|
Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.
Topics: Ammonia; Humans; Liposomes; Models, Theoretical; Reproducibility of Results; Spectrometry, Fluorescence; Topoisomerase I Inhibitors; Topotecan | 2015 |
FF-10850, a Novel Liposomal Topotecan Achieves Superior Antitumor Activity via Macrophage- and Ammonia-Mediated Payload Release in the Tumor Microenvironment.
Topics: Ammonia; Animals; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Macrophages; Mice; Ovarian Neoplasms; Topoisomerase I Inhibitors; Topotecan; Tumor Microenvironment | 2023 |